Arash Aghel, MD
Cardiovascular Disease (Cardiology) · Torrance
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
- Since medical school
- 23 years
- Graduated 2003
Offices
4 locations · Torrance Memorial Medical Center · Torrance Health Association Inc · Southern California Hospitalist Network Medical Group Inc · Cor Healthcare Medical Associates
Hospitals listed: Providence Little Company of Mary Med Ctr Torrance · Torrance Memorial Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Aghel’s office to ask if they take your plan before you enroll.
State licence records
1 licence
- Colorado DR.53643Physician · since 2014 · expires 2023-04-30Specialty on the licence: CardiologyExpiredNo board action on this licenceCheck it with the stateWhat they told the state about themselves
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Providence Little Company of Mary Med Ctr TorranceTorrance, CAAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.472, Oct 2024 – Sep 2025
- Torrance Memorial Medical CenterTorrance, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Cedars Sinai Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 82% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.36 (1.11 to 1.61), Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 15.79 (10.51 to 21.07) · 1,494 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.21 (0.72 to 1.71) · 9,154 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.328, Oct 2024 – Sep 2025
See every measure and the patient survey for Providence Little Company of Mary Med Ctr Torrance
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 8 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.472 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.09 (0.11 to 2.07) · 1,022 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.59 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 129.31 (75.73 to 182.88) · 65 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 36 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 70 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.4 · 353 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 361 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 495 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 3,150 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 5,786 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.06 to 0.45) · 5,832 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.21 (2.1 to 6.32) · 1,135 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.81 (0.22 to 3.4) · 375 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.8 to 3.86) · 1,086 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.78 (2.28 to 15.28) · 389 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.58 (1.19 to 7.98) · 377 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2 (0.51 to 3.49) · 247 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 0.93) · 4,918 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 127 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.892 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.225 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.363 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 283 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 709 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 10.5 · 149 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.9 · 428 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -13.8 · 369 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 551 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 59 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 168 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.8 (8.9 to 15.5) · 642 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 331 cases | No different | Jan 2024 – Dec 2024 |
What patients said (414 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for Torrance Memorial Medical Center
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.36 (1.11 to 1.61) | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 15.79 (10.51 to 21.07) · 1,494 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.21 (0.72 to 1.71) · 9,154 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.328 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.72) · 2,154 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 171.72 (128.91 to 214.54) · 121 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 36 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8 · 136 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 176 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.8 · 766 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 806 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 608 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 7,587 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.28 (0.1 to 0.47) · 11,109 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.03 to 0.39) · 11,330 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.13 (2.41 to 5.85) · 2,964 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0.13 to 3.16) · 1,513 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.66 (1.3 to 4.01) · 2,802 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.24 (2.35 to 8.14) · 1,479 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.55 (0.11 to 2.98) · 650 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2 · 962 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.023 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.646 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.751 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.259 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.658 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 1,578 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 21.1 · 183 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.5 · 900 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.9 · 800 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.1 · 1,223 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.3) · 26 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7 to 15) · 26 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 928 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12 · 65 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21 · 316 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.5 to 16.1) · 624 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 781 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,607 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$272,620
Medicare paid this office $272,620 for 751 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 332 | $44,997 | $100 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 12 | $28,603 | $1,505 |
| Long return visit (40+ min) | 132 | $27,198 | $141 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 143 | $24,638 | $168 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 55 | $15,908 | $44 |
See all 27 services
| Return visit (30+ min) | 332 | $44,997 | $100 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 12 | $28,603 | $1,505 |
| Long return visit (40+ min) | 132 | $27,198 | $141 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 143 | $24,638 | $168 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 55 | $15,908 | $44 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 33 | $12,326 | $54 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 30 | $11,825 | $41 |
| New patient visit (45+ min) | 87 | $11,743 | $135 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $10,258 | $98 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 42 | $7,911 | $42 |
| New patient visit (60+ min) | 42 | $7,768 | $185 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 31 | $6,133 | $34 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $5,974 | $427 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 26 | $5,190 | $185 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $5,102 | $142 |
| Telephone medical discussion with physician, 21-30 minutes | 30 | $3,501 | $109 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 12 | $1,955 | $109 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 32 | $1,808 | $57 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 26 | $1,523 | $59 |
| Short return visit (20+ min) | 18 | $1,332 | $74 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 13 | $1,041 | $74 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 133 | $914 | $6 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 73 | $888 | $11 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 11 | $622 | $57 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 18 | $375 | $21 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 14 | $255 | $18 |
| Heart rhythm recording of continous external ekg over 8-15 days | 18 | $188 | $10 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 15 | More than 39% of doctors who do this |
| Leg revascularization (restoring blood flow) | 18 | More than 71% of doctors who do this |
| Varicose vein removal | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | – | – | – | 15 | 30 | 19 |
| Removal of plaque in arteries of leg | 16 | 18 | – | – | – | – |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 13 | 14 | – | – | – | – |
| Balloon dilation of artery of leg, initial vessel | 19 | – | – | – | – | – |
| Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | 18 | – | – | – | – | – |
| Insertion of stent in groin artery, initial vessel | 15 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
751 Original Medicare patients in 2024. Average age 78 · Under 65 4% · 85 and older 22% · Women 50% · Also on Medicaid 17% · Health risk score 1.63. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 47% · Diabetes 40% · Chronic kidney disease 38% · Heart failure 34% · Atrial fibrillation 32% · Depression 23% · Cancer 19% · COPD 19% · Stroke 15% · Dementia 12%.
The office billed $769,595, Medicare allowed $355,338 and paid $272,620; for 3,046 services of 82 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 751 | 3,046 | 78 | 1.63 | $769,595 | $272,620 |
| 2023 | 830 | 1,798 | 77 | 1.97 | $520,771 | $208,224 |
| 2022 | 773 | 1,610 | 77 | 1.65 | $397,613 | $168,204 |
| 2021 | 671 | 1,442 | 75 | 1.70 | $700,560 | $132,984 |
| 2020 | 771 | 1,660 | 74 | 1.81 | $1,292,956 | $139,352 |
| 2019 | 1,109 | 2,429 | 74 | 1.62 | $1,594,516 | $198,818 |
| 2018 | 1,203 | 2,417 | 74 | 1.66 | $1,029,081 | $168,144 |
| 2017 | 1,213 | 2,379 | 75 | 1.64 | $585,378 | $174,199 |
| 2016 | 503 | 1,415 | 75 | 1.49 | $467,062 | $152,403 |
| 2015 | 417 | 1,070 | 75 | 1.53 | $338,482 | $116,064 |
| 2014 | 174 | 426 | 72 | 1.34 | $118,136 | $39,919 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Return visit (30+ min) | 336 | $48,617 | $100 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 21 | $46,761 | $1,559 |
| Long return visit (40+ min) | 162 | $34,225 | $143 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 86 | $16,324 | $176 |
| New patient visit (60+ min) | 48 | $8,770 | $183 |
| New patient visit (45+ min) | 56 | $7,212 | $129 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 20 | $3,419 | $110 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 359 | $2,892 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $2,305 | $177 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 11 | $1,915 | $174 |
| Short return visit (20+ min) | 18 | $1,421 | $71 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 15 | $1,121 | $49 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 76 | $1,021 | $12 |
| Review by radiologist of abdominal aorta image | 11 | $710 | $55 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 12 | $666 | $56 |
2022: 13 services
| Long return visit (40+ min) | 194 | $38,790 | $137 |
| Return visit (30+ min) | 276 | $35,799 | $102 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 15 | $24,746 | $1,650 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 82 | $15,047 | $184 |
| New patient visit (60+ min) | 71 | $12,363 | $174 |
| New patient visit (45+ min) | 59 | $7,883 | $134 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 292 | $2,408 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 140 | $1,829 | $12 |
| Short return visit (20+ min) | 23 | $1,717 | $75 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 15 | $1,701 | $113 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 18 | $1,246 | $48 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $347 | $29 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 19 | $243 | $13 |
2021: 13 services
| Long return visit (40+ min) | 190 | $32,701 | $152 |
| Return visit (30+ min) | 142 | $15,772 | $107 |
| New patient visit (60+ min) | 79 | $15,091 | $191 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 62 | $12,071 | $192 |
| New patient visit (45+ min) | 31 | $4,409 | $142 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $3,578 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 236 | $3,109 | $13 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 14 | $2,305 | $165 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 204 | $1,657 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,514 | $72 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 15 | $769 | $51 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 35 | $427 | $10 |
| Ultrasonic guidance for blood vessel access | 16 | $259 | $11 |
2020: 24 services
| Long return visit (40+ min) | 118 | $14,641 | $107 |
| Return visit (30+ min) | 118 | $10,826 | $77 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 159 | $9,326 | $58 |
| Removal of plaque in artery of leg, initial vessel | 11 | $8,095 | $578 |
| Removal of plaque in arteries of leg | 15 | $7,586 | $421 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 38 | $7,377 | $194 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $6,946 | $434 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 12 | $6,537 | $545 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $6,189 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,386 | $163 |
| New patient visit (60+ min) | 29 | $4,840 | $167 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 14 | $3,273 | $234 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 305 | $2,633 | $7 |
| New patient visit (45+ min) | 15 | $1,903 | $127 |
| Review by radiologist of arm or leg artery image | 21 | $1,782 | $71 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 92 | $1,336 | $13 |
| Review by radiologist of abdominal aorta image | 22 | $1,277 | $58 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 89 | $1,137 | $10 |
| Short return visit (20+ min) | 15 | $937 | $59 |
| Review by radiologist of both arms or legs arteries image | 11 | $874 | $79 |
| Ultrasonic guidance for blood vessel access | 34 | $661 | $12 |
| Review by radiologist of additional artery image | 14 | $609 | $38 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 13 | $80 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $32 | $2 |
2019: 30 services
| Long return visit (40+ min) | 154 | $19,756 | $109 |
| Return visit (30+ min) | 194 | $16,714 | $78 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 25 | $13,766 | $393 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $9,134 | $155 |
| New patient visit (60+ min) | 54 | $8,993 | $167 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 16 | $8,870 | $554 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 45 | $8,409 | $183 |
| Replacement of aortic valve through the skin and femoral artery | 12 | $8,359 | $697 |
| Removal of plaque in arteries of leg | 14 | $7,857 | $491 |
| Balloon dilation of artery of leg, initial vessel | 17 | $7,568 | $398 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 64 | $7,479 | $80 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 128 | $7,346 | $57 |
| Insertion of stent in groin artery, initial vessel | 15 | $5,861 | $391 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 550 | $4,569 | $7 |
| Balloon dilation of artery of leg | 14 | $4,167 | $278 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 13 | $3,309 | $255 |
| Critical care, first 30-74 minutes | 12 | $2,908 | $182 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | 17 | $2,465 | $137 |
| Review by radiologist of both arms or legs arteries image | 27 | $2,370 | $79 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 169 | $2,319 | $13 |
| Review by radiologist of arm or leg artery image | 28 | $2,270 | $71 |
| Review by radiologist of abdominal aorta image | 36 | $1,830 | $46 |
| New patient visit (45+ min) | 15 | $1,807 | $120 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 118 | $1,499 | $10 |
| Ultrasonic guidance for blood vessel access | 53 | $937 | $12 |
| Hospital discharge day management, more than 30 minutes | 12 | $935 | $78 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 11 | $846 | $77 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 12 | $845 | $65 |
| Short return visit (20+ min) | 11 | $571 | $52 |
| Review by radiologist of additional artery image | 13 | $199 | $14 |
2018: 27 services
| Long return visit (40+ min) | 149 | $19,581 | $106 |
| Replacement of aortic valve through the skin and femoral artery | 20 | $13,582 | $679 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 210 | $11,624 | $55 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 21 | $11,202 | $533 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 22 | $11,183 | $414 |
| New patient visit (60+ min) | 74 | $10,632 | $144 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 59 | $10,394 | $173 |
| Return visit (30+ min) | 130 | $10,015 | $71 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $7,567 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $6,587 | $78 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 571 | $4,304 | $6 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 13 | $3,021 | $232 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 187 | $2,765 | $13 |
| New patient visit (45+ min) | 22 | $2,288 | $104 |
| Hospital discharge day management, more than 30 minutes | 25 | $1,987 | $79 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 12 | $1,738 | $145 |
| Ultrasound study of arm and leg arteries | 43 | $1,606 | $37 |
| Review by radiologist of both arms or legs arteries image | 20 | $1,531 | $73 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 105 | $1,241 | $10 |
| Review by radiologist of arm or leg artery image | 12 | $897 | $64 |
| Review by radiologist of abdominal aorta image | 19 | $851 | $43 |
| Ultrasonic guidance for blood vessel access | 19 | $342 | $11 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $271 | $14 |
| Ultrasound of heart, follow-up | 13 | $261 | $20 |
| Review by radiologist of additional artery image | 13 | $195 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $84 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $44 | $2 |
2017: 25 services
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 40 | $22,094 | $552 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 34 | $17,384 | $414 |
| Return visit (30+ min) | 186 | $17,160 | $79 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 75 | $13,279 | $175 |
| Long return visit (40+ min) | 98 | $12,900 | $108 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $10,997 | $159 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 188 | $9,085 | $47 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $7,392 | $77 |
| New patient visit (60+ min) | 39 | $5,881 | $151 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 601 | $5,148 | $7 |
| New patient visit (45+ min) | 28 | $3,439 | $123 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 199 | $3,003 | $13 |
| Initial hospital observation care per day, typically 70 minutes | 18 | $2,827 | $149 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 13 | $2,786 | $214 |
| Critical care, first 30-74 minutes | 13 | $2,759 | $162 |
| Hospital discharge day management, more than 30 minutes | 28 | $2,267 | $81 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 11 | $1,996 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $1,503 | $48 |
| Short return visit (20+ min) | 20 | $1,076 | $51 |
| Hospital observation care on day of discharge | 15 | $876 | $58 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 79 | $843 | $10 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $822 | $68 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $230 | $15 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $89 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $43 | $3 |
2016: 25 services
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 35 | $19,650 | $561 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 31 | $16,795 | $410 |
| Return visit (30+ min) | 143 | $16,134 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $12,755 | $159 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 41 | $8,355 | $199 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 77 | $8,262 | $83 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 104 | $5,051 | $49 |
| Long return visit (40+ min) | 36 | $4,492 | $115 |
| New patient visit (45+ min) | 38 | $4,425 | $116 |
| New patient visit (60+ min) | 28 | $4,150 | $148 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 22 | $3,589 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $3,343 | $56 |
| Hospital discharge day management, more than 30 minutes | 34 | $2,794 | $82 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 163 | $2,707 | $13 |
| Short return visit (20+ min) | 42 | $2,612 | $54 |
| Initial hospital observation care per day, typically 70 minutes | 11 | $1,623 | $148 |
| Hospital observation care on day of discharge | 25 | $1,450 | $58 |
| Transitional care management services for problem of at least moderate complexity | 11 | $1,438 | $131 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 19 | $1,241 | $65 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 13 | $1,029 | $79 |
| Ultrasound study of arm and leg arteries | 14 | $902 | $64 |
| New patient visit (30+ min) | 12 | $862 | $72 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 31 | $523 | $16 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 17 | $101 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $46 | $3 |
2015: 18 services
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 34 | $20,235 | $562 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $13,447 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $12,867 | $82 |
| Return visit (30+ min) | 86 | $9,573 | $80 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 31 | $6,677 | $215 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $6,268 | $448 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 55 | $4,223 | $57 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 85 | $4,204 | $49 |
| New patient visit (45+ min) | 31 | $3,948 | $127 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 20 | $3,163 | $158 |
| Initial hospital observation care per day, typically 70 minutes | 18 | $2,680 | $141 |
| Hospital discharge day management, more than 30 minutes | 29 | $2,574 | $86 |
| Short return visit (20+ min) | 33 | $2,087 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 88 | $1,499 | $13 |
| Transitional care management services for problem of at least moderate complexity | 11 | $1,443 | $131 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 12 | $1,050 | $81 |
| Hospital observation care on day of discharge | 16 | $871 | $54 |
| New patient visit (30+ min) | 11 | $813 | $74 |
2014: 11 services
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 12 | $6,570 | $548 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,233 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $4,174 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $3,693 | $57 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 43 | $2,279 | $51 |
| New patient visit (45+ min) | 20 | $2,261 | $113 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 11 | $2,091 | $190 |
| Return visit (30+ min) | 22 | $2,045 | $82 |
| New patient visit (30+ min) | 13 | $1,106 | $85 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 11 | $782 | $71 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 43 | $716 | $13 |
Medicaid work
$444 in 2024
Medicaid paid $444 for 71 billed services this clinician did in 2024, up to 31 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 71 | $444 |
| 2024 | 71 | 1 | 31 | $444 |
| 2023 | 217 | 1 | 87 | $1,805 |
| 2022 | 136 | 1 | 40 | $1,055 |
| 2021 | 314 | 2 | 121 | $2,724 |
| 2020 | 342 | 2 | 127 | $2,983 |
| 2019 | 426 | 1 | 130 | $2,613 |
| 2018 | 504 | 2 | 120 | $3,143 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 217 | $1,805 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 136 | $1,055 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 300 | $2,147 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 14 | $577 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 327 | $2,139 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 15 | $844 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 426 | $2,613 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 492 | $2,942 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 12 | $201 |
Drugs they prescribed that Part D paid
$682,008
Pharmacies billed $682,008 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,450 generic and fewer than 11 brand-name prescriptions · $682,008 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 269 | $350,381 | $1,303 |
| Entresto | 59 | $86,058 | $1,459 |
| Farxiga | 41 | $43,509 | $1,061 |
| Xarelto | 41 | $36,539 | $891 |
| Repatha Sureclick | 26 | $32,377 | $1,245 |
See all 44 drugs
| Eliquis | 269 | $350,381 | $1,303 |
| Entresto | 59 | $86,058 | $1,459 |
| Farxiga | 41 | $43,509 | $1,061 |
| Xarelto | 41 | $36,539 | $891 |
| Repatha Sureclick | 26 | $32,377 | $1,245 |
| Repatha | 21 | $20,277 | $966 |
| Jardiance | 12 | $18,281 | $1,523 |
| Brilinta | 14 | $14,261 | $1,019 |
| Praluent | 19 | $9,234 | $486 |
| Atorvastatin | 357 | $4,118 | $12 |
| Metoprolol | 285 | $3,816 | $13 |
| Rosuvastatin | 175 | $3,341 | $19 |
| Amiodarone | 26 | $2,723 | $105 |
| Nebivolol | 26 | $2,531 | $97 |
| Ezetimibe | 77 | $2,481 | $32 |
| Clopidogrel | 179 | $1,941 | $11 |
| Ranolazine Er | 15 | $1,048 | $70 |
| Losartan | 109 | $1,013 | $9 |
| Carvedilol | 124 | $1,006 | $8 |
| Flecainide Acetate | 18 | $953 | $53 |
| Amlodipine Besylate | 224 | $931 | $4 |
| Potassium Chloride | 29 | $731 | $25 |
| Telmisartan | 20 | $634 | $32 |
| Furosemide | 104 | $582 | $6 |
| Benazepril | 35 | $526 | $15 |
| Olmesartan Medoxomil | 22 | $511 | $23 |
| Telmisartan-Hydrochlorothiazid | 12 | $500 | $42 |
| Sotalol Af | 15 | $477 | $32 |
| Diltiazem 24hr Er (Cd) | 18 | $454 | $25 |
| Hydralazine | 29 | $443 | $15 |
| Metoprolol | 59 | $439 | $7 |
| Lisinopril | 82 | $431 | $5 |
| Valsartan | 13 | $423 | $33 |
| Sotalol | 14 | $312 | $22 |
| Pravastatin | 17 | $308 | $18 |
| Nitroglycerin | 14 | $268 | $19 |
| Losartan-Hydrochlorothiazide | 23 | $262 | $11 |
| Hydrochlorothiazide | 46 | $214 | $5 |
| Bumetanide | 11 | $203 | $18 |
| Ramipril | 23 | $187 | $8 |
| Spironolactone | 28 | $181 | $6 |
| Simvastatin | 30 | $173 | $6 |
| Warfarin | 11 | $94 | $9 |
| Isosorbide Mononitrate Er | 16 | $63 | $4 |
Year by year
| 2024 | 3,016 | 452 | None | None | $682,008 |
| 2023 | 2,881 | 445 | None | None | $595,027 |
| 2022 | 2,741 | 487 | 0% (0) | None | $433,461 |
| 2021 | 1,573 | 419 | None | 14% | $182,813 |
| 2020 | 1,440 | 243 | None | 15% | $151,781 |
| 2019 | 1,337 | 264 | None | 15% | $122,807 |
| 2018 | 1,580 | 251 | None | 21% | $138,864 |
| 2017 | 1,404 | 231 | 0% (0) | 22% | $105,862 |
| 2016 | 865 | 160 | 0% (0) | 27% | $51,470 |
| 2015 | 483 | 90 | None | 27% | $19,434 |
| 2014 | 85 | 30 | 0% (0) | 41% | $5,659 |
| 2013 | 33 | None | 0% (0) | None | $543 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 41 drugs
| Eliquis | 265 | $309,290 | $1,167 |
| Entresto | 36 | $58,165 | $1,616 |
| Xarelto | 55 | $46,911 | $853 |
| Repatha Sureclick | 32 | $34,280 | $1,071 |
| Farxiga | 23 | $17,283 | $751 |
| Brilinta | 20 | $16,025 | $801 |
| Repatha | 14 | $9,586 | $685 |
| Praluent | 14 | $7,460 | $533 |
| Atorvastatin | 378 | $6,709 | $18 |
| Rosuvastatin | 154 | $4,564 | $30 |
| Metoprolol | 234 | $4,408 | $19 |
| Clopidogrel | 147 | $2,409 | $16 |
| Nebivolol | 23 | $2,346 | $102 |
| Ezetimibe | 52 | $2,342 | $45 |
| Flecainide Acetate | 23 | $1,681 | $73 |
| Losartan | 105 | $1,603 | $15 |
| Amlodipine Besylate | 186 | $1,453 | $8 |
| Carvedilol | 102 | $1,398 | $14 |
| Amlodipine-Olmesartan | 13 | $1,350 | $104 |
| Diltiazem 24hr Er (Cd) | 29 | $1,153 | $40 |
| Amiodarone | 31 | $1,146 | $37 |
| Furosemide | 115 | $992 | $9 |
| Bumetanide | 20 | $949 | $47 |
| Valsartan | 12 | $918 | $77 |
| Lisinopril | 87 | $817 | $9 |
| Benazepril | 41 | $780 | $19 |
| Potassium Chloride | 37 | $704 | $19 |
| Isosorbide Mononitrate Er | 28 | $693 | $25 |
| Telmisartan | 16 | $682 | $43 |
| Pravastatin | 31 | $612 | $20 |
| Losartan-Hydrochlorothiazide | 24 | $556 | $23 |
| Sotalol Af | 16 | $556 | $35 |
| Metoprolol | 50 | $528 | $11 |
| Sotalol | 32 | $527 | $16 |
| Olmesartan Medoxomil | 23 | $442 | $19 |
| Hydrochlorothiazide | 54 | $423 | $8 |
| Hydralazine | 22 | $413 | $19 |
| Simvastatin | 36 | $298 | $8 |
| Ramipril | 21 | $230 | $11 |
| Atenolol | 20 | $152 | $8 |
| Spironolactone | 11 | $105 | $10 |
2022: 39 drugs
| Eliquis | 254 | $241,198 | $950 |
| Entresto | 33 | $46,961 | $1,423 |
| Xarelto | 44 | $30,405 | $691 |
| Repatha Sureclick | 20 | $11,863 | $593 |
| Multaq | 11 | $8,512 | $774 |
| Atorvastatin | 392 | $6,326 | $16 |
| Rosuvastatin | 125 | $5,231 | $42 |
| Metoprolol | 200 | $4,089 | $20 |
| Ranolazine Er | 28 | $4,007 | $143 |
| Telmisartan | 42 | $2,175 | $52 |
| Ezetimibe | 39 | $2,036 | $52 |
| Clopidogrel | 149 | $2,008 | $13 |
| Flecainide Acetate | 32 | $1,993 | $62 |
| Amlodipine Besylate | 215 | $1,598 | $7 |
| Losartan | 95 | $1,323 | $14 |
| Valsartan | 14 | $1,199 | $86 |
| Diltiazem 24hr Er (Cd) | 36 | $1,103 | $31 |
| Carvedilol | 113 | $1,042 | $9 |
| Amlodipine-Olmesartan | 15 | $929 | $62 |
| Fenofibrate | 12 | $813 | $68 |
| Nitroglycerin | 18 | $726 | $40 |
| Nifedipine Er | 22 | $724 | $33 |
| Amiodarone | 22 | $704 | $32 |
| Olmesartan Medoxomil | 17 | $646 | $38 |
| Potassium Chloride | 27 | $606 | $22 |
| Furosemide | 93 | $601 | $6 |
| Pravastatin | 25 | $563 | $23 |
| Isosorbide Mononitrate Er | 24 | $537 | $22 |
| Hydralazine | 24 | $498 | $21 |
| Lisinopril | 83 | $486 | $6 |
| Hydrochlorothiazide | 73 | $466 | $6 |
| Sotalol | 32 | $462 | $14 |
| Benazepril | 34 | $417 | $12 |
| Digoxin | 11 | $392 | $36 |
| Metoprolol | 50 | $347 | $7 |
| Simvastatin | 41 | $332 | $8 |
| Warfarin | 13 | $255 | $20 |
| Ramipril | 18 | $129 | $7 |
| Atenolol | 15 | $110 | $7 |
2021: 21 drugs
| Eliquis | 85 | $80,677 | $949 |
| Xarelto | 42 | $42,510 | $1,012 |
| Rosuvastatin | 85 | $3,484 | $41 |
| Atorvastatin | 232 | $2,786 | $12 |
| Metoprolol | 121 | $2,144 | $18 |
| Ranolazine Er | 13 | $2,131 | $164 |
| Clopidogrel | 184 | $1,491 | $8 |
| Ezetimibe | 18 | $1,134 | $63 |
| Diltiazem 24hr Er (Cd) | 17 | $944 | $56 |
| Valsartan | 15 | $797 | $53 |
| Amlodipine Besylate | 126 | $652 | $5 |
| Carvedilol | 62 | $599 | $10 |
| Losartan | 61 | $590 | $10 |
| Potassium Chloride | 46 | $496 | $11 |
| Nitroglycerin | 12 | $342 | $28 |
| Lisinopril | 74 | $305 | $4 |
| Spironolactone | 15 | $248 | $17 |
| Furosemide | 53 | $245 | $5 |
| Isosorbide Mononitrate Er | 14 | $208 | $15 |
| Hydrochlorothiazide | 26 | $180 | $7 |
| Metoprolol | 34 | $128 | $4 |
2020: 21 drugs
| Eliquis | 54 | $48,843 | $905 |
| Xarelto | 54 | $47,957 | $888 |
| Repatha Sureclick | 13 | $8,835 | $680 |
| Ranolazine Er | 13 | $3,388 | $261 |
| Clopidogrel | 183 | $2,972 | $16 |
| Atorvastatin | 185 | $2,904 | $16 |
| Metoprolol | 105 | $2,584 | $25 |
| Rosuvastatin | 75 | $1,945 | $26 |
| Potassium Chloride | 56 | $1,009 | $18 |
| Lisinopril | 83 | $648 | $8 |
| Amlodipine Besylate | 93 | $631 | $7 |
| Losartan | 45 | $609 | $14 |
| Carvedilol | 68 | $574 | $8 |
| Ezetimibe | 17 | $557 | $33 |
| Furosemide | 56 | $299 | $5 |
| Diltiazem 24hr Er | 15 | $298 | $20 |
| Nitroglycerin | 12 | $292 | $24 |
| Metoprolol | 48 | $290 | $6 |
| Spironolactone | 15 | $288 | $19 |
| Warfarin | 16 | $227 | $14 |
| Pantoprazole | 15 | $191 | $13 |
2019: 19 drugs
| Xarelto | 37 | $36,238 | $979 |
| Eliquis | 51 | $34,396 | $674 |
| Brilinta | 15 | $12,515 | $834 |
| Atorvastatin | 201 | $4,706 | $23 |
| Clopidogrel | 177 | $3,461 | $20 |
| Metoprolol | 124 | $3,373 | $27 |
| Rosuvastatin | 64 | $1,870 | $29 |
| Ezetimibe | 18 | $869 | $48 |
| Potassium Chloride | 41 | $755 | $18 |
| Amlodipine Besylate | 92 | $624 | $7 |
| Lisinopril | 65 | $610 | $9 |
| Metoprolol | 58 | $521 | $9 |
| Carvedilol | 44 | $498 | $11 |
| Losartan | 38 | $474 | $12 |
| Furosemide | 55 | $323 | $6 |
| Warfarin | 27 | $323 | $12 |
| Nitroglycerin | 15 | $298 | $20 |
| Pantoprazole | 16 | $245 | $15 |
| Spironolactone | 16 | $203 | $13 |
2018: 21 drugs
| Xarelto | 52 | $39,016 | $750 |
| Eliquis | 33 | $27,861 | $844 |
| Brilinta | 30 | $15,861 | $529 |
| Atorvastatin | 246 | $6,552 | $27 |
| Metoprolol | 148 | $5,887 | $40 |
| Clopidogrel | 150 | $3,380 | $23 |
| Rosuvastatin | 72 | $2,884 | $40 |
| Amlodipine Besylate | 139 | $903 | $6 |
| Ezetimibe | 17 | $867 | $51 |
| Potassium Chloride | 37 | $829 | $22 |
| Lisinopril | 77 | $681 | $9 |
| Metoprolol | 80 | $634 | $8 |
| Losartan | 52 | $513 | $10 |
| Warfarin | 32 | $490 | $15 |
| Nitroglycerin | 18 | $419 | $23 |
| Furosemide | 66 | $378 | $6 |
| Carvedilol | 44 | $366 | $8 |
| Spironolactone | 22 | $355 | $16 |
| Pantoprazole | 20 | $336 | $17 |
| Doxazosin Mesylate | 11 | $265 | $24 |
| Hydrochlorothiazide | 11 | $49 | $4 |
2017: 23 drugs
| Xarelto | 44 | $25,348 | $576 |
| Eliquis | 22 | $21,978 | $999 |
| Brilinta | 32 | $17,736 | $554 |
| Atorvastatin | 259 | $6,221 | $24 |
| Rosuvastatin | 69 | $3,359 | $49 |
| Metoprolol | 91 | $3,322 | $37 |
| Clopidogrel | 133 | $3,110 | $23 |
| Flecainide Acetate | 12 | $3,095 | $258 |
| Amlodipine Besylate | 153 | $775 | $5 |
| Nitroglycerin | 26 | $661 | $25 |
| Potassium Chloride | 23 | $660 | $29 |
| Metoprolol | 77 | $591 | $8 |
| Lisinopril | 92 | $552 | $6 |
| Telmisartan | 15 | $360 | $24 |
| Carvedilol | 36 | $322 | $9 |
| Furosemide | 59 | $299 | $5 |
| Losartan | 24 | $250 | $10 |
| Spironolactone | 17 | $179 | $11 |
| Pantoprazole | 15 | $146 | $10 |
| Isosorbide Mononitrate Er | 11 | $144 | $13 |
| Warfarin | 16 | $120 | $8 |
| Hydrochlorothiazide | 21 | $80 | $4 |
| Atenolol | 19 | $75 | $4 |
2016: 15 drugs
| Xarelto | 17 | $14,571 | $857 |
| Brilinta | 21 | $11,892 | $566 |
| Eliquis | 12 | $7,270 | $606 |
| Atorvastatin | 209 | $3,659 | $18 |
| Clopidogrel | 108 | $1,863 | $17 |
| Metoprolol | 65 | $1,635 | $25 |
| Potassium Chloride | 18 | $381 | $21 |
| Lisinopril | 58 | $328 | $6 |
| Amlodipine Besylate | 55 | $313 | $6 |
| Carvedilol | 45 | $283 | $6 |
| Metoprolol | 36 | $202 | $6 |
| Furosemide | 48 | $191 | $4 |
| Spironolactone | 11 | $108 | $10 |
| Losartan | 12 | $91 | $8 |
| Hydrochlorothiazide | 12 | $59 | $5 |
2015: 8 drugs
| Brilinta | 17 | $4,779 | $281 |
| Metoprolol | 91 | $1,881 | $21 |
| Atorvastatin | 109 | $1,843 | $17 |
| Clopidogrel | 58 | $713 | $12 |
| Lisinopril | 53 | $254 | $5 |
| Carvedilol | 34 | $173 | $5 |
| Furosemide | 16 | $78 | $5 |
| Metoprolol | 14 | $52 | $4 |
2014: 2 drugs
| Atorvastatin | 22 | $420 | $19 |
| Metoprolol | 14 | $341 | $24 |
Money from drug and device companies
$1,476 in 2025
| 2025 | 15 | 62 | None | $1,476 |
| 2024 | 17 | 57 | None | $1,396 |
| 2023 | 17 | 33 | None | $1,152 |
| 2022 | 7 | 11 | None | $436 |
| 2021 | 4 | 6 | None | $194 |
| 2020 | 7 | 16 | None | $317 |
| 2019 | 9 | 19 | None | $403 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Avvigo Guidance System | $548 | 26 payments
|
| Pfizer | Eliquis | $172 | 7 payments
|
| Novartis Pharmaceuticals | Leqvio | $140 | 5 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $131 | 6 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $129 | 3 payments
|
| Recor Medical | Paradise Ultrasound Renal Denervation System | $108 | 5 payments
|
See all 62 published payments
| Edwards Lifesciences | Meals · 2025-12-23 | Sapien 3 Ultra Resilia | $64 |
| Recor Medical | Meals · 2025-12-18 | Paradise Ultrasound Renal Denervation System | $18 |
| Medtronic | Meals · 2025-12-09 | Venaseal | $23 |
| Boston Scientific | Meals · 2025-11-19 | Avvigo Guidance System | $27 |
| Pfizer | Meals · 2025-11-19 | Eliquis | $26 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-11-14 | Lifevest | $22 |
| Recor Medical | Meals · 2025-11-14 | Paradise Ultrasound Renal Denervation System | $20 |
| Novartis Pharmaceuticals | Meals · 2025-11-12 | Leqvio | $26 |
| Boston Scientific | Meals · 2025-10-24 | Avvigo Guidance System | $19 |
| Inspire Medical Systems | Meals · 2025-10-22 | Inspire | $24 |
| Pfizer | Meals · 2025-10-15 | Eliquis | $26 |
| Boston Scientific | Meals · 2025-10-10 | Rotapro | $26 |
| Recor Medical | Meals · 2025-10-03 | Paradise Ultrasound Renal Denervation System | $34 |
| Novartis Pharmaceuticals | Meals · 2025-09-24 | Leqvio | $29 |
| Scpharmaceuticals | Meals · 2025-09-10 | Furoscix | $17 |
| Pfizer | Meals · 2025-08-28 | Eliquis | $22 |
| Novartis Pharmaceuticals | Meals · 2025-08-27 | Leqvio | $30 |
| Novartis Pharmaceuticals | Meals · 2025-08-27 | Leqvio | $30 |
| Boston Scientific | Meals · 2025-08-20 | Avvigo Guidance System | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-08-01 | Lifevest | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-07-31 | Lifevest | $20 |
| Boston Scientific | Meals · 2025-07-31 | Rotapro | $71 |
| Boston Scientific | Meals · 2025-07-30 | Avvigo Guidance System | $16 |
| Regeneron Healthcare Solutions | Meals · 2025-07-23 | Evkeeza | $37 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-07-22 | Lifevest | $19 |
| Edwards Lifesciences | Meals · 2025-07-22 | Sapien 3 Ultra Resilia | $29 |
| Boston Scientific | Meals · 2025-07-21 | Wolverine Coronary Cutting Balloon | $13 |
| Boston Scientific | Meals · 2025-07-02 | Comet | $20 |
| Recor Medical | Meals · 2025-07-01 | Paradise Ultrasound Renal Denervation System | $18 |
| Boston Scientific | Meals · 2025-06-25 | Comet | $17 |
| Pfizer | Meals · 2025-06-25 | Eliquis | $25 |
| GlaxoSmithKline | Meals · 2025-06-24 | Trelegy Ellipta | $22 |
| Recor Medical | Meals · 2025-06-06 | Paradise Ultrasound Renal Denervation System | $18 |
| Boston Scientific | Meals · 2025-06-04 | General - Atherectomy | $20 |
| Novartis Pharmaceuticals | Meals · 2025-06-04 | Leqvio | $25 |
| Boston Scientific | Meals · 2025-05-27 | Avvigo Guidance System | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-05-23 | Lifevest | $24 |
| Pfizer | Meals · 2025-05-21 | Eliquis | $26 |
| Boston Scientific | Meals · 2025-05-16 | Permanent Sled Bag | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-05-14 | Evkeeza | $37 |
| Boston Scientific | Meals · 2025-05-11 | Avvigo Guidance System | $21 |
| Boston Scientific | Meals · 2025-05-09 | Avvigo Guidance System | $6 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-07 | Jardiance | $29 |
| Boston Scientific | Meals · 2025-05-01 | Avvigo Guidance System | $18 |
| Lilly USA | Meals · 2025-04-30 | Mounjaro | $19 |
| Boston Scientific | Meals · 2025-04-23 | Avvigo Guidance System | $18 |
| Pfizer | Meals · 2025-04-16 | Eliquis | $22 |
| Boston Scientific | Meals · 2025-04-15 | Avvigo Guidance System | $22 |
| Boston Scientific | Meals · 2025-04-04 | Synergy | $24 |
| Boston Scientific | Meals · 2025-03-28 | Encore 26 | $19 |
| Boston Scientific | Meals · 2025-03-19 | General - Balloon Catheters | $18 |
| Boston Scientific | Meals · 2025-03-13 | Avvigo Guidance System | $21 |
| Boston Scientific | Meals · 2025-02-13 | Avvigo Guidance System | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-12 | Wainua | $21 |
| Pfizer | Meals · 2025-02-05 | Eliquis | $25 |
| Boston Scientific | Meals · 2025-01-30 | Avvigo Guidance System | $16 |
| Edwards Lifesciences | Meals · 2025-01-28 | Sapien 3 Ultra Resilia | $36 |
| Boston Scientific | Meals · 2025-01-24 | Watchdog | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-01-16 | Lifevest | $22 |
| Boston Scientific | Meals · 2025-01-16 | Avvigo Guidance System | $22 |
| Amgen | Meals · 2025-01-15 | Repatha | $19 |
| Boston Scientific | Meals · 2025-01-06 | Avvigo Guidance System | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,396
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $333 | 8 payments
|
| Boston Scientific | Avvigo Guidance System | $245 | 14 payments
|
| Pfizer | Eliquis | $158 | 7 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $118 | 5 payments
|
| Janssen Pharmaceuticals | Xarelto | $86 | 4 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $74 | 3 payments
|
| Novartis Pharmaceuticals | Leqvio | $69 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $56 | 2 payments
|
| Inspire Medical Systems | Inspire | $43 | 1 payment
|
| Medtronic | Symplicity G3 | $42 | 1 payment
|
| Esperion Therapeutics | Nexletol | $39 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $36 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $24 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $23 | 1 payment
|
| Amgen | Repatha | $19 | 1 payment
|
| Becton Dickinson and | Lutonix Drug Coated Balloon | $17 | 1 payment
|
| Kestra Medical Technology Services | Assure Wcd | $14 | 1 payment
|
2023: $1,152
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $275 | 4 payments
|
| Inari Medical | Flowtriever Catheter, S | $176 | 1 payment
|
| Medtronic | Closurefast | $120 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $98 | 5 payments
|
| Pfizer | Eliquis | $70 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $66 | 3 payments
|
| Boston Scientific | Eluvia | $48 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $48 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $45 | 2 payments
|
| Harmony Biosciences | Wakix | $40 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $33 | 2 payments
|
| Jazz Pharmaceuticals | Xywav | $29 | 1 payment
|
| Amgen | Repatha | $24 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $23 | 1 payment
|
| iRhythm Technologies | Zio Xt Patch | $23 | 1 payment
|
| Electromed | Smartvest | $17 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $17 | 1 payment
|
2022: $436
| Philips Electronics North America | (5044) Mcot | $254 | 1 payment
|
| Medtronic | Venaseal | $67 | 3 payments
|
| Novo Nordisk | Ozempic | $46 | 3 payments
|
| Regeneron Healthcare Solutions | Praluent | $23 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $20 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $18 | 1 payment
|
| Inogen | Inogenone | $9 | 1 payment
|
2021: $194
| Cardiovascular Systems | Diamondback Peripheral | $112 | 2 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $49 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $17 | 1 payment
|
| Boston Scientific | Watchman | $15 | 1 payment
|
2020: $317
| Cardiovascular Systems | Peripheral Orbital Atherectomy System | $197 | 9 payments
|
| Janssen Pharmaceuticals | Xarelto | $36 | 2 payments
|
| Biotronik | None | $21 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $18 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $18 | 1 payment
|
| Bard Peripheral Vascular | Venovo | $14 | 1 payment
|
| Boston Scientific | Watchman | $13 | 1 payment
|
2019: $403
| Boston Scientific | Watchman | $129 | 2 payments
|
| Amgen | Corlanor | $113 | 7 payments
|
| Novartis Pharmaceuticals | Entresto | $53 | 3 payments
|
| Asahi Intecc USA | Asahi Ptca Guide Wire | $31 | 1 payment
|
| Cardiovascular Systems | Peripheral Orbital Atherectomy System | $24 | 2 payments
|
| Edwards Lifesciences | None | $15 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $15 | 1 payment
|
| Portola Pharmaceuticals | Andexxa | $13 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $11 | 1 payment
|
Professional record
- NPI
- 1477729713
- Licence
- CO DR.0053643Colorado DR.53643: Expired
- Group
- Torrance Memorial Medical Center · Torrance Health Association Inc · Southern California Hospitalist Network Medical Group Inc · Cor Healthcare Medical Associates
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Cardiology (207RC0000X)
- Mailing address
- 2841 Lomita Blvd Ste 100, Torrance, CA, 90505
- NPI first listed
- 2008-05-06
- NPI last updated
- 2026-04-29
- NPI record certified
- 2026-04-29
This is when the NPI record was last certified, not a medical board exam.